Novavax (NASDAQ: NVAX)
Novavax Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Novavax Company Info
Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.
News & Analysis
Down 60% From Its 52-Week High, Is Novavax Stock a Buy?
Is there still too much risk surrounding this business?
1 Beaten-Down Stock That's Still Not Worth Buying
For this biotech, a rebound seems far too unlikely.
Two Beaten-Down Stocks That Could Soar 170% and 630%, Respectively, According to Wall Street
Could these biotech companies still win in the vaccine market and beyond?
Is Novavax a Buy Now?
The stock has dropped 98% over the past three years.
1 of the Biggest Risks Facing Novavax Has Now Been Resolved: Is Now the Time to Buy the Stock?
Can the stock's recent rally continue?
Has Novavax Just Solved Its Biggest Problem?
The biotech company recently settled a dispute with a major customer.
Better Bull Market Buy: Novavax vs. Pfizer
Bull markets usually favor stocks with promising growth prospects.
Where Will Novavax Be in 10 Years?
Without any windfalls on the horizon, times are dire for this biotech.
Valuation
Earnings Transcripts
Novavax Inc (NVAX) Q3 2021 Earnings Call Transcript
NVAX earnings call for the period ending September 30, 2021.
Novavax (NVAX) Q1 2020 Earnings Call Transcript
NVAX earnings call for the period ending March 31, 2020.
Novavax Inc (NVAX) Q2 2019 Earnings Call Transcript
NVAX earnings call for the period ending June 30, 2019.
Novavax Inc (NVAX) Q1 2019 Earnings Call Transcript
NVAX earnings call for the period ending March 31, 2019.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.